» Articles » PMID: 30515408

Effectiveness of Low to Moderate Physical Exercise Training on the Level of Low-Density Lipoproteins: A Systematic Review

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Dec 6
PMID 30515408
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Regular exercise reduces risk factors associated with cardiovascular disease (CVD). Elevated low-density lipoprotein (LDL) contributes to atherosclerosis formation, which is associated with an increased risk of CVD. The relationship between exercise therapy and lipid levels has been widely studied, but it is established that high-intensity exercise improves lipid profile. However, the effectiveness of low- to moderate-intensity exercise in altering LDL levels is controversial. This review aims to identify the current evidence and existing gaps in literature in this area.

Methods: We searched and reviewed various randomized controlled clinical trials in the electronic databases EMBASE, CINAHL, the Web of Science, Cochrane, Pedro, Medline (PubMed), and Google Scholar using the keywords "low and moderate aerobic training," "exercise", "low-density lipoproteins," "cholesterol," "atherosclerosis," and "coronary artery diseases markers." We included studies that involved low- and/or moderate-intensity exercise training in apparently healthy adults over a period of 8 weeks and its effect on LDL levels. We selected a total of 11 studies from 469; nine were randomized controlled trials and two were systematic reviews.

Results: Aerobic exercise of both low and moderate intensity resulted in a significant reduction of total cholesterol. Effects on low-density lipoprotein levels were significant, and most of the studies showed changes in the level without significant relation to the type of exercise. At the same time, exercise improved the health status and physical fitness of all the participants in the included studies.

Conclusion: This study found that low- and moderate-intensity exercise and low-density lipoprotein levels were not proven to be significantly related, except in a few studies that were limited to dyslipidemia population.

Citing Articles

The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone).

Errigo A, Dore M, Portoghese M, Pes G Nutrients. 2025; 17(5).

PMID: 40077635 PMC: 11901585. DOI: 10.3390/nu17050765.


Comparative Efficacy and Safety of Different Low-Dose Platelet Inhibitors in Patients With Coronary Heart Disease: A Bayesian Network Meta-Analysis.

Li C, Ren Z, Liu J, Liang S, Liu H, Wang D J Evid Based Med. 2024; 17(4):822-832.

PMID: 39708364 PMC: 11684504. DOI: 10.1111/jebm.12671.


Associations of step accelerations and cardiometabolic risk markers in early adulthood.

Stenback V, Lehtonen I, Leppaluoto J, Gagnon D, Jarvelin M, Tulppo M Eur J Public Health. 2024; 35(1):128-133.

PMID: 39656794 PMC: 11832146. DOI: 10.1093/eurpub/ckae199.


Cholesterol crystals in the pathogenesis of atherosclerosis.

Baumer Y, Irei J, Boisvert W Nat Rev Cardiol. 2024; .

PMID: 39558130 DOI: 10.1038/s41569-024-01100-3.


Functional Foods and Adapted Physical Activity as New Adjuvant Therapy for Chronic Kidney Disease Patients.

Marrone G, Murri A, Urciuoli S, Di Lauro M, Grazioli E, Vignolini P Nutrients. 2024; 16(14).

PMID: 39064768 PMC: 11279472. DOI: 10.3390/nu16142325.


References
1.
Kraus W, Houmard J, Duscha B, Knetzger K, Wharton M, McCartney J . Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002; 347(19):1483-92. DOI: 10.1056/NEJMoa020194. View

2.
Smith J, Dykes R, Douglas J, Krishnaswamy G, Berk S . Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 1999; 281(18):1722-7. DOI: 10.1001/jama.281.18.1722. View

3.
Szapary P, Bloedon L, Foster G . Physical activity and its effects on lipids. Curr Cardiol Rep. 2003; 5(6):488-92. DOI: 10.1007/s11886-003-0112-2. View

4.
Wang Y, Xu D . Effects of aerobic exercise on lipids and lipoproteins. Lipids Health Dis. 2017; 16(1):132. PMC: 5498979. DOI: 10.1186/s12944-017-0515-5. View

5.
Brunzell J, Davidson M, Furberg C, Goldberg R, Howard B, Stein J . Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2008; 51(15):1512-24. DOI: 10.1016/j.jacc.2008.02.034. View